We are live on ! Find out more
CYTK icon

Cytokinetics
CYTK

277 hedge funds and large institutions have $4.88B invested in Cytokinetics in 2022 Q4 according to their latest regulatory filings, with 38 funds opening new positions, 109 increasing their positions, 83 reducing their positions, and 36 closing their positions.

New
Increased
Maintained
Reduced
Closed

356% more call options, than puts

Call options by funds: $48.3M | Put options by funds: $10.6M

31% more repeat investments, than reductions

Existing positions increased: 109 | Existing positions reduced: 83

1.22% more ownership

Funds ownership: 111.13% → 112.35% (+1.2%)

6% more first-time investments, than exits

New positions opened: 38 | Existing positions closed: 36

0% more funds holding

Funds holding: 277 → 277 (0)

1% less capital invested

Capital invested by funds: $4.95B → $4.88B (-$70.7M)

9% less funds holding in top 10

Funds holding in top 10: 11 → 10 (-1)

Holders
277
Holders Change
–
Holders Change %
0%
% of All Funds
4.45%
Holding in Top 10
10
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-9.09%
% of All Funds
0.16%
New
38
Increased
109
Reduced
83
Closed
36
Calls
$48.3M
Puts
$10.6M
Net Calls
+$37.7M
Net Calls Change
-$3.12M

Top Buyers

Rank Fund Capital Flow
1
Wellington Management Group
Wellington Management Group
Massachusetts
+$73.4M
2
State Street
State Street
Massachusetts
+$34M
3
American Century Companies
American Century Companies
Missouri
+$30.9M
4
Balyasny Asset Management
Balyasny Asset Management
Illinois
+$25.7M
5
EAM
Eventide Asset Management
Massachusetts
+$23.9M

Top Sellers

Rank Fund Capital Flow
1
DCM
Driehaus Capital Management
Illinois
-$53.4M
2
CC
Commodore Capital
New York
-$43.3M
3
DM
Deerfield Management
New York
-$39.4M
4
Lord, Abbett & Co
Lord, Abbett & Co
New Jersey
-$35.9M
5
Victory Capital Management
Victory Capital Management
Texas
-$22.1M
Name Holding Trade Value Shares
Change 		Change in
Stake
PRC
301
Pearl River Capital
Michigan
– -$259K -5,341 Closed
GTCM
302
Gyon Technologies Capital Management
New Jersey
– -$245K -5,064 Closed
MSU
303
Mizuho Securities USA
New York
– -$240K -4,947 Closed
ECM
304
Evergreen Capital Management
Washington
– -$204K -4,217 Closed
IB
305
Intrust Bank
Kansas
– -$202K -4,163 Closed
API
306
Advisor Partners II
California
– -$201K -4,156 Closed
EW
307
Evoke Wealth
California
– -$24K -505 Closed
EC
308
Elequin Capital
New York
– -$13K -265 Closed
MAM
309
Meeder Asset Management
Ohio
– -$13K -263 Closed
AF
310
Allworth Financial
California
– -$1K -26 Closed
EI
311
Ellevest Inc
New York
– -$1K -19 Closed
CG
312
Cutler Group
California
– +$430 +10 New
CAL
313
Capital Advisors Ltd
Ohio
– +$6.45K +150 New
9 10 11 12
13

CYTK Hedge Fund Activity: Q4 2022 in Review

277 of the 6,221 institutional investors tracked by Wall St. Rank reported a position in Cytokinetics (CYTK) for Q4 2022, worth a combined $4.88B — down 1.4% from $4.95B a quarter earlier.

Buyers outnumbered sellers: 38 funds opened new CYTK positions and 36 closed out — a net gain of 2 holders — while 109 added to existing stakes and 83 trimmed.

The largest buyer was Wellington Management Group, adding an estimated $73.4M. The largest seller was Driehaus Capital Management, cutting an estimated $53.4M.

  • 277 institutional investors held Cytokinetics (CYTK) as of Q4 2022, unchanged from Q3 2022.
  • Funds reported $4.88B of Cytokinetics stock for Q4 2022, down 1.4% quarter-over-quarter.
  • 38 funds opened new Cytokinetics positions in Q4 2022 and 36 closed out, a net change of +2 holders.
  • The largest Cytokinetics buyer in Q4 2022 was Wellington Management Group, an estimated $73.4M added.
  • The largest Cytokinetics seller in Q4 2022 was Driehaus Capital Management, an estimated $53.4M sold.

Based on aggregated 13F filings for Q4 2022.